Causes is now part of Brigade – the world's first network for voters.
Join Brigade to take action on issues and elections that matter to you.
Cure Cystic Fibrosis
Phase 3 Combination Studies of Ivacaftor (Kalydeco™) and Lumacaftor (VX-809) Show Positive Results in Most Common CF Mutation
Did everyone hear the great news?!
Jun 24, 2014